Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients

The notion of personalized medicine demands proper prognostic biomarkers to guide the optimal therapy for an invasive breast cancer patient. However, various risk prediction models based on conventional clinicopathological factors and emergent molecular assays have been frequently limited by either...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Gangqin, Guo, Wenhui, Kang, Deyong, Ma, Jianli, Fu, Fangmeng, Qiu, Lida, Zheng, Liqin, He, Jiajia, Fang, Na, Chen, Jianhua, Li, Jingtong, Zhuo, Shuangmu, Liao, Xiaoxia, Tu, Haohua, Li, Lianhuang, Zhang, Qingyuan, Wang, Chuan, Boppart, Stephen A., Chen, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847696/
https://www.ncbi.nlm.nih.gov/pubmed/33537084
http://dx.doi.org/10.7150/thno.55921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847696/
https://www.ncbi.nlm.nih.gov/pubmed/33537084
http://dx.doi.org/10.7150/thno.55921

Ejemplares similares